Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression

Advances in Cancer Research

Volumn 123, Issue , 2014, Pages 255-275

  Bourguignon, Lilly Y W ^a   Shiina, Marisa ^a   Li, Jian Jian ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer stem cells; CD44; Chemoresistance; Matrix hyaluronan; MicroRNAs; Radiation resistance; Tumor progression

Indexed keywords

ANKYRIN; CD44S ANTIGEN; CD44V3 ANTIGEN; CELL SURFACE RECEPTOR; GUANOSINE TRIPHOSPHATASE; HERMES ANTIGEN; HYALURONIC ACID; MATRIX METALLOPROTEINASE; MICRORNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CD44 PROTEIN, HUMAN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; CANCER RECURRENCE; CANCER RESISTANCE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL RENEWAL; CYTOSKELETON; EXTRACELLULAR MATRIX; HUMAN; METASTASIS; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; STEM CELL NICHE; TUMOR GROWTH; ANIMAL; APOPTOSIS; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DISEASE COURSE; DRUG RESISTANCE; METABOLISM; MOUSE; NEOPLASMS; TUMOR EMBOLISM; TUMOR INVASION;

ANIMALS; ANKYRINS; ANTIGENS, CD44; APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CYTOSKELETON; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; HUMANS; HYALURONIC ACID; MICE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; NEOPLASTIC STEM CELLS; PHENOTYPE; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84904888972     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800092-2.00010-1     Document Type: Chapter

References (80)

1. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:3983-3988.
2. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., Post S., et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008, 27:2128-2136.
3. Astachov L., Vago R., Aviv M., Nevo Z. Hyaluronan and mesenchymal stem cells: From germ layer to cartilage and bone. Frontiers in Bioscience (Landmark Edition) 2011, 16:261-276.
4. Auvinen P., Tammi R., Tammi M., Johansson R., Kosma V.M. Expression of CD44s, CD44v3 and CD44v6 in benign and malignant breast lesions: Correlation and colocalization with hyaluronan. Histopathology 2005, 47:420-428.
5. Baker E.K., El-Osta A. MDR1, chemotherapy and chromatin remodeling. Cancer Biology & Therapy 2004, 3:819-824.
6. Bennett V., Baines A.J. Spectrin and ankyrin-based pathways: Metazoan inventions for integrating cells into tissues. Physiological Reviews 2001, 81:1353-1392.
7. Bhalla K.N. Microtubule-targeted anticancer agents and apoptosis. Oncogene 2003, 22:9075-9086.
8. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 1997, 3:730-737.
9. Bourguignon L.Y. CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. Journal of Mammary Gland Biology and Neoplasia 2001, 6:287-297.
10. Bourguignon L.Y. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Seminars in Cancer Biology 2008, 18:251-259.
11. Bourguignon L.Y., Earle C., Wong G., Spevak C.C., Krueger K. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene 2012, 31:149-160.
12. Bourguignon L.Y., Gilad E., Brightman A., Diedrich F., Singleton P. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. The Journal of Biological Chemistry 2006, 281:14026-14040.
13. Bourguignon L.Y., Gunja-Smith Z., Iida N., Zhu H.B., Young L.J., Muller W.J., et al. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. Journal of Cellular Physiology 1998, 176:206-215.
14. Bourguignon L.Y., Peyrollier K., Gilad E., Brightman A. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells. The Journal of Biological Chemistry 2007, 282:1265-1280.
15. Bourguignon L.Y., Peyrollier K., Xia W., Gilad E. Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. The Journal of Biological Chemistry 2008, 283:17635-17651.
16. Bourguignon L.Y., Singleton P.A., Diedrich F., Stern R., Gilad E. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. The Journal of Biological Chemistry 2004, 279:26991-27007.
17. Bourguignon L.Y., Singleton P.A., Zhu H., Diedrich F. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. The Journal of Biological Chemistry 2003, 278:29420-29434.
18. Bourguignon L.Y., Singleton P.A., Zhu H., Zhou B. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. The Journal of Biological Chemistry 2002, 277:39703-39710.
19. Bourguignon L.Y., Spevak C.C., Wong G., Xia W., Gilad E. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. The Journal of Biological Chemistry 2009, 284:26533-26546.
20. Bourguignon L.Y., Wong G., Earle C., Chen L. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. The Journal of Biological Chemistry 2012, 287:32800-32824.
21. Bourguignon L.Y., Zhu H., Chu A., Iida N., Zhang L., Hung M.C. Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. The Journal of Biological Chemistry 1997, 272:27913-27918.
22. Bourguignon L.Y., Zhu H., Shao L., Chen Y.W. CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. The Journal of Biological Chemistry 2000, 275:1829-1838.
23. Bourguignon L.Y., Zhu H., Shao L., Chen Y.W. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. The Journal of Biological Chemistry 2001, 276:7327-7336.
24. Bourguignon L.Y., Zhu H., Shao L., Zhu D., Chen Y.W. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motility and the Cytoskeleton 1999, 43:269-287.
25. Bourguignon L.Y., Zhu H., Zhou B., Diedrich F., Singleton P.A., Hung M.C. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. The Journal of Biological Chemistry 2001, 276:48679-48692.
26. Bourguignon L.Y., Zhu D., Zhu H. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression. Frontiers in Bioscience 1998, 3:d637-d649.
27. Boyer L.A., Lee T.I., Cole M.F., Johnstone S.E., Levine S.S., Zucker J.P., et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956.
28. Bradford C.R., Zhu S., Ogawa H., Ogawa T., Ubell M., Narayan A., et al. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head & Neck 2003, 25:654-661.
29. Brooks P.C., Strömblad S., Sanders L.C., von Schalscha T.L., Aimes R.T., Stetler-Stevenson W.G., et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996, 85:683-693.
30. Cao N., Li S., Wang Z., Ahmed K.M., Degnan M.E., Fan M., et al. NF-kappaB-mediated HER2 overexpression in radiation-adaptive resistance. Radiation Research 2009, 171:9-21.
31. Card D.A., Hebbar P.B., Li L., Trotter K.W., Komatsu Y., Mishina Y., et al. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Molecular and Cellular Biology 2008, 28:6426-6438.
32. Chen W.T. Proteases associated with invadopodia, and their role in degradation of extracellular matrix. Enzyme & Protein 1996, 49:59-71.
33. Dong C., Wilhelm D., Koopman P. Sox genes and cancer. Genome Research 2004, 105:442-447.
34. Duru N., Fan M., Candas D., Menaa C., Liu H.C., Nantajit D., et al. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells. Clinical Cancer Research 2012, 18:6634-6647.
35. Franzmann E.J., Weed D.T., Civantos F.J., Goodwin W.J., Bourguignon L.Y. A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression. Otolaryngology and Head and Neck Surgery 2001, 124:426-432.
36. Fritz G., Just I., Kaina B. RhoGTPase over-expressed in human tumors. International Journal of Cancer 1999, 81:682-687.
37. Gewirtz D.A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochemical Pharmacology 1999, 57:727-741.
38. Godar S., Ince T.A., Bell G.W., Feldser D., Donaher J.L., Bergh J., et al. Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression. Cell 2008, 134:62-73.
39. Gum R., Lengyel E., Juarez J., Chen J.H., Sato H., Seiki M., et al. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. The Journal of Biological Chemistry 1996, 271:10672-10680.
40. Gunthert U., Hoffman M., Rudy W., Reber S., Zoller M., Haußmann I., et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991, 65:13-24.
41. Guo G., Wang T., Gao Q., Tamae D., Wong P., Chen T., et al. Expression of ErbB2 enhances radiation-induced NF-kappaB activation. Oncogene 2004, 23:535-545.
42. Hall A. Rho GTPase and the actin cytoskeleton. Science 1998, 279:509-514.
43. Harnett P.R., Kirsten F., Tattersall M.H. Drug resistance in clinical practice: Patterns of treatment failure in advanced breast and ovarian cancer. Journal of Clinical Oncology 1986, 4:952-957.
44. Haylock D.N., Nilsson S.K. The role of hyaluronic acid in hemopoietic stem cell biology. Regenerative Medicine 2006, 1:437-445.
45. Higgins C.F. ABC transporters: From microorganisms to man. Annual Review of Cell Biology 1992, 8:67-113.
46. Hunter A.M., LaCasse E.C., Korneluk R.G. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 2007, 12:1543-1568.
47. Iida N., Bourguignon L.Y. New CD44 splice variants associated with human breast cancers. Journal of Cellular Physiology 1995, 162:127-133.
48. Iida N., Bourguignon L.Y. Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis. Journal of Cellular Physiology 1997, 171:152-160.
49. Itano N., Kimata K. Expression cloning and molecular characterization of HAS protein, a eukaryotic hyaluronan synthase. The Journal of Biological Chemistry 1996, 271:9875-9878.
50. Kashyap V., Rezende N.C., Scotland K.B., Shaffer S.M., Persson J.L., Gudas L.J., et al. Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells and Development 2009, 18:1093-1108.
51. Kato T., Duffey D.C., Ondrey F.G., Dong G., Chen Z., Cook J.A., et al. Cisplatin and radiation sensitivity in human head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF-kappaB. Head & Neck 2000, 22:748-759.
52. Lambert S., Yu H., Prchal J.T., Lawler J., Ruff P., Speicher D., et al. cDNA sequence for human erythrocyte ankyrin. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:1730-1734.
53. Laurent T.C., Fraser J.R.E. Hyaluronan. FASEB Journal 1992, 6:2397-2404.
54. Lee J.Y., Spicer A.P. Hyaluronan: A multifunctional, megadalton, stealth molecule. Current Opinion in Cell Biology 2000, 12:581-586.
55. Li X., Lim B. RhoGTPases and their role in cancer. Oncology Research 2003, 13:323-331.
56. Liu H., Deng S., Zhao Z., Zhang H., Xiao J., Song W., et al. Oct4 regulates the miR-302 cluster in P19 mouse embryonic carcinoma cells. Molecular Biology Reports 2011, 38:2155-2160.
57. Lokeshwar V.B., Fregien N., Bourguignon L.Y. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. The Journal of Cell Biology 1994, 126:1099-1109.
58. Lu J., Bai L., Sun H., Nikolovska-Coleska Z., McEachern D., Qiu S., et al. SM-164: A novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1/2 and XIAP. Cancer Research 2008, 68:9384-9393.
59. Lux S.E., John K.M., Bennett V. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature 1990, 344:36-42.
60. Mack B., Gires O. CD44s and CD44v6 expression in head and neck epithelia. PLoS One 2008, 3:e3360.
61. Misra S., Ghatak S., Zoltan-Jones A., Toole B.P. Regulation of multidrug resistance in cancer cells by hyaluronan. The Journal of Biological Chemistry 2003, 278:25285-25288.
62. Polette M., Nawrocki B., Gilles C., Sato H., Seiki M., Tournier J.M., et al. MT-MMP expression and localisation in human lung and breast cancers. Virchows Archiv 1996, 428:29-35.
63. Screaton G.R., Bell M.V., Jackson D.G., Cornelis F.B., Gerth U., Bell J.I. Genomic structure of DNA coding the lymphocyte homing receptor CD44 reveals 12 alternatively spliced exons. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:12160-12164.
64. Sheridan C., Kishimoto H., Fuchs R.K., Mehrotra S., Bhat-Nakshatri P., Turner C.H., et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: An early step necessary for metastasis. Breast Cancer Research 2006, 8:R59.
65. Shiga H., Rasmussen A.A., Johnston P.G., Langmacher M., Baylor A., Lee M., et al. Prognostic value of c-erbB2 and other markers in patients treated with chemotherapy for recurrent head and neck cancer. Head & Neck 2000, 22:599-608.
66. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., McGuire W.L. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182.
67. Spicer A.P., Nguyen T.K. Mammalian hyaluronan synthases: Investigation of functional relationships in vivo. Biochemical Society Transactions 1999, 27:109-115.
68. Suwa H., Ohshio G., Imamura T., Watanabe G., Arii S., Imamura M., et al. Overexpression of the rho C gene correlates with progression of ductal adenocarcinoma of the pancreas. British Journal of Cancer 1998, 77:147-152.
69. Toole B.P. Hyaluronan in morphogenesis. Seminars in Cell & Developmental Biology 2001, 12:79-87.
70. Toole B.P., Hascall V.C. Hyaluronan and tumor growth. The American Journal of Pathology 2002, 161:745-747.
71. Turley E.A., Nobel P.W., Bourguignon L.Y.W. Signaling properties of hyaluronan receptors. The Journal of Biological Chemistry 2002, 277:4589-4592.
72. Underhill C. CD44: The hyaluronan receptor. Journal of Cell Science 1992, 103:293-298.
73. Wang S.J., Bourguignon L.Y. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Archives of Otolaryngology-Head & Neck Surgery 2006, 132:771-778.
74. Wang S.J., Bourguignon L.Y. Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. The American Journal of Pathology 2011, 178:956-963.
75. Wang S.J., Peyrollier K., Bourguignon L.Y. The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer. Archives of Otolaryngology-Head & Neck Surgery 2007, 133:281-288.
76. Wang S.J., Wong G., de Heer A.M., Xia W., Bourguignon L.Y. CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope 2009, 119:1518-1530.
77. Wang S.J., Wreesmann V.B., Bourguignon L.Y. Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer. Head & Neck 2007, 29:550-558.
78. Weige P.H., Hascall V.C., Tammi M. Hyaluronan synthases. The Journal of Biological Chemistry 1997, 272:13997-14000.
79. Yamada Y., Itano N., Zako M., Yoshida M., Lenas P., Niimi A., et al. The gene structure and promoter sequence of mouse hyaluronan synthase 1. The Biochemical Journal 1998, 330:1223-1227.
80. Zhu D., Bourguignon L.Y. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation. Cell Motility and the Cytoskeleton 1998, 39:209-222.